Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bullboard Posts
Post by frohlir944on Mar 26, 2018 11:43am
241 Views
Post# 27781575

Significant (upcoming) Milestones

Significant (upcoming) Milestones"her appointment gives me great confidence in our ability to execute on our clinical strategy and to meet the significant milestones we have set for ourselves for the coming months" This has to be one of the most powerful lines in the press release, because it reinforces that patients, science and stockholders are all going to benefit greatly from all that is happening!

it has been evident to all that have paid attention and read between the lines in MD&A that much was happening, it's great that we are starting to see some of it unfold,  but the really big reveals are still to come.  Truly exiting times ahead for all.  (Patients will benefit, science will benefit, and stockholders will benefit)

Bullboard Posts